Page last updated: 2024-10-24

celecoxib and Death, Sudden

celecoxib has been researched along with Death, Sudden in 1 studies

Death, Sudden: The abrupt cessation of all vital bodily functions, manifested by the permanent loss of total cerebral, respiratory, and cardiovascular functions.

Research Excerpts

ExcerptRelevanceReference
" cerebral infarction, myocardial infarction and unstable angina pectoris, among rofecoxib and naproxen users in comparison to diclofenac users."3.76Rofecoxib, but not celecoxib, increases the risk of thromboembolic cardiovascular events in young adults-a nationwide registry-based study. ( Einarsdottir, R; Gudbjornsson, B; Halldorsson, M; Johannsson, M; Sigvaldason, H; Thorgeirsson, G; Thorsteinsson, SB; Zoega, H, 2010)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gudbjornsson, B1
Thorsteinsson, SB1
Sigvaldason, H1
Einarsdottir, R1
Johannsson, M1
Zoega, H1
Halldorsson, M1
Thorgeirsson, G1

Other Studies

1 other study available for celecoxib and Death, Sudden

ArticleYear
Rofecoxib, but not celecoxib, increases the risk of thromboembolic cardiovascular events in young adults-a nationwide registry-based study.
    European journal of clinical pharmacology, 2010, Volume: 66, Issue:6

    Topics: Angina, Unstable; Celecoxib; Cerebral Infarction; Cyclooxygenase 2 Inhibitors; Databases, Factual; D

2010